Cash Flow Statement

Altimmune (ALT) Change in Acquisitions & Divestments (2017 - 2025)

Altimmune (ALT) has disclosed Change in Acquisitions & Divestments for 6 consecutive years, with $9.4 million as the latest value for Q4 2025.

  • Quarterly Change in Acquisitions & Divestments fell 65.0% to $9.4 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $153.0 million through Dec 2025, up 75.15% year-over-year, with the annual reading at $153.0 million for FY2025, 75.15% up from the prior year.
  • Change in Acquisitions & Divestments for Q4 2025 was $9.4 million at Altimmune, down from $105.5 million in the prior quarter.
  • The five-year high for Change in Acquisitions & Divestments was $105.5 million in Q2 2025, with the low at $9.4 million in Q4 2025.
  • Average Change in Acquisitions & Divestments over 4 years is $30.0 million, with a median of $26.0 million recorded in 2023.
  • Peak annual rise in Change in Acquisitions & Divestments hit 441.28% in 2025, while the deepest fall reached 65.0% in 2025.
  • Over 4 years, Change in Acquisitions & Divestments stood at $25.0 million in 2021, then increased by 3.38% to $25.9 million in 2023, then rose by 3.78% to $26.8 million in 2024, then tumbled by 65.0% to $9.4 million in 2025.
  • According to Business Quant data, Change in Acquisitions & Divestments over the past three periods came in at $9.4 million, $105.5 million, and $38.0 million for Q4 2025, Q2 2025, and Q1 2025 respectively.